Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces that its genomic interpretation software is now CE marked under the In Vitro Diagnostics Directive (98/79/EC). With the In Vitro Diagnostic (IVD) designation, Congenica’s clinical decision support platform can make the transition [...]

Future development and growth trends Shimadzu, one of the world leaders in analytical instrumentation, has appointed Jürgen Semmler as the new Managing Director of its European organization from July 1st, 2021. Previously head of Shimadzu Deutschland, he succeeds Jürgen Kwass, who led Shimadzu Europa from 2003 to the present and is now retiring. Semmler and [...]

SOUTH SAN FRANCISCO, Calif.-- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its synthetic RNA reference controls for the SARS-CoV-2 Delta (B.1.617.2) and B.1.617.3 variants first identified in India and spreading rapidly worldwide. “Just [...]

2020 CSR report highlights commitment to employees, customers, partners, and the global community SANTA CLARA, Calif. --  Agilent Technologies, Inc. (NYSE: A) today issued its 21st annual Corporate Social Responsibility (CSR) report. The report highlights the company’s progress in critical environmental, social and governance (ESG) areas as well its commitment to employees, customers, partners, and the global [...]

FREMONT, Calif. -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the pricing of its initial public offering of an aggregate of 16,749,330 shares of its common stock at a price to the public of $17.00 per share. The gross proceeds to Cytek from the offering, [...]

908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced outcomes of its joint innovation partnership with Transcenta, a global biotherapeutics company. Transcenta has implemented 908 Devices’ technologies within its Process and Product Development Center and Manufacturing Facility in Hangzhou, China to facilitate their biopharma analytical workflows [...]

AMSTERDAM -- LUMICKS, a leading next generation life science tools company renowned for its innovative platforms for Dynamic Single-Molecule and Cell Avidity analysis, has installed its ground-breaking z-Movi® Cell Avidity Analyzer at INmune Bio (NASDAQ: INMB). INmune Bio is a clinical stage biotechnology company developing new therapies that modulate the innate immune system to treat cancer [...]

New 20/15 Visioneers and Eagle Genomics Partnership to Promote Global Microbiome Education and Standardization New joint white paper demonstrates fundamental role of microbiome in ongoing “Bio Revolution” and Causal network science to be critical tool for translating highly-complex, multi-dimensional microbiome data into actionable insights. Hereford, Pennsylvania, USA & Cambridge, UK - Today, 20/15 Visioneers LLC. (20/15), a [...]

SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today affirmed its commitment to re-acquire GRAIL, a healthcare company focused on multi-cancer early detection. “This acquisition is procompetitive, and we have offered far-reaching structural and behavioral remedies to address any potential concerns. Illumina will continue to work with the European Commission (EC) to ensure that it has [...]

RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today published its first sustainability report. The report highlights key actions taken in 2020, as well as initiatives underway to accelerate future sustainability goals that advance the Company's [...]